PRWeb The Leader Press Release Distribution
See How PRWeb Works

We're here to help 1-866-640-6397

Login Create Free Account


All Press Releases for December 16, 2003 Subscribe to this News Feed    
 

Top Pharmaceutical and Biotech companies are keen to outsource $200 Million of R&D work to India.

Proximare Inc., a leading pharmaceutical consulting firm estimates that after the boom of IT outsourcing, it is now the turn of R&D outsourcing, especially in the biotech and pharma industries in India.

New Delhi, India (PRWEB) December 16, 2003 --The Financial Express, one of India's leading newspapers, wrote a cover page story featuring Proximare Inc. and its managing director Mr. Nailesh A. Bhatt on the subject of R&D and outsourcing in the pharmaceutical industry.

With the headlines of "Top Pharma, Biotech Cos Keen To Outsource $200 M Research," this article appeared on December 8, 2003 nationwide in India.

"We have received a great deal of positive response to this article from our clients, business associates and pharmaceutical industry professionals in India and internationally;" Proximare's managing director Nailesh A. Bhatt said.

For more information on this article, please visit http://www.financialexpress.com/print.php?content_id=47861

About Proximare Inc.
Proximare is a leading management & strategy consulting firm that exclusively serves the pharmaceutical, biotech and related industries. Proximare creates value for all its clients by creating and implementing sound strategies that can be implemented in the most efficient, economical and effective manner. Please visit http://www.proximare.com for more information.

Proximare is a registered trademark of Proximare Inc.

###

OPTIONS
Printer Friendly Version
Email this story to a colleague
CONTACT INFORMATION
Nailesh A. Bhatt
PROXIMARE INC.
732-297-7007
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your PRWeb News Management Console.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appears here.